Correction to: Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey

Pharmaceut Med. 2020 Feb;34(1):81. doi: 10.1007/s40290-019-00319-7.

Authors

Stella Stergiopoulos¹, Moritz Fehrle², Patrick Caubel³, Louise Tan⁴, Louise Jebson⁴

Affiliations

¹ Tufts Center for the Study of Drug Development, Tufts University School of Medicine, 75 Kneeland Street, Ste 1100, Boston, MA, 02111, USA. [email protected].
² Bayer AG, 51368, Leverkusen, Germany.
³ Pfizer Inc, New York, NY, 10017, USA.
⁴ Pvnet®, Navitas Life Sciences GmbH, 60528, Frankfurt, Germany.

PMID: 32048211
DOI: 10.1007/s40290-019-00319-7

Abstract

The correct name of the second author should be "Moritz Fehrle", and not "Mortiz Fehrle" as given in the original publication of the article.

Publication types

Published Erratum